BRCA1 Mutation Clinical Trial
Official title:
Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling: Effective Familial OutReach Via Tele-genetics (EfFORT) Trial & Supporting Test Result Interpretation and Variant Education (STRIVE) Trial
The purpose of this study is to evaluate a cascade genetic testing intervention. Cascade testing is the process of offering genetic testing to people who are at risk of having inherited a possibly harmful gene change that has been found in their family. This process is repeated as more people within the family are found to have the gene change. The study will look at how often genetic testing occurs when healthcare providers have permission to reach out to family members to recommend genetic testing and to help those who are interested get tested. The study will look at whether this cascade testing intervention is practical and effective. The study would like to see how this approach of healthcare providers reaching out directly to family members compares with the usual approach of patients telling their family members about the recommendation to get genetic testing.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Withdrawn |
NCT03032614 -
Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients
|
Phase 2 | |
Not yet recruiting |
NCT04055038 -
Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04566952 -
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
|
Phase 2 | |
Recruiting |
NCT04499534 -
BRCA1/2 Flu Vaccine
|
||
Recruiting |
NCT05537844 -
Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma
|
||
Active, not recruiting |
NCT03685331 -
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer
|
Phase 1 | |
Recruiting |
NCT05097274 -
The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a BRCA Gene Mutation.
|
||
Completed |
NCT03428399 -
Depression and Body Image Distress Following Mastectomy With Reconstruction
|
||
Completed |
NCT02957981 -
The Genetic Education for Men Trial: Web-Based Education vs. Standard Care
|
N/A | |
Recruiting |
NCT04556071 -
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer
|
Phase 2 | |
Completed |
NCT04651920 -
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
|
||
Completed |
NCT02974842 -
Pre-Salpingo-Oophorectomy Pilot Study of MAKO 7 Device Performance
|
||
Active, not recruiting |
NCT03351803 -
BRCA Founder OutReach (BFOR) Study
|
||
Withdrawn |
NCT05062174 -
Breast Cancer BRCA1 Carriers: a Pilot Study
|
||
Suspended |
NCT04151368 -
Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy
|
N/A | |
Active, not recruiting |
NCT04273542 -
Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening
|
N/A | |
Recruiting |
NCT05694715 -
Combination Therapy in Cancers With Mutations in DNA Repair Genes
|
Phase 1 | |
Recruiting |
NCT06395519 -
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
|
Phase 1 | |
Recruiting |
NCT05410951 -
LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients
|